MyAverix Finance
NS · Healthcare
Vivo Bio Tech Ltd (511509)
Pharmaceuticals & Biotechnology
Vivo Bio Tech Ltd (511509) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $501.70M, P/E ratio is -26.29, net margin is 5.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 511509
Vivo Bio Tech Ltd (511509) — FAQ
What is Vivo Bio Tech Ltd's market cap?
Vivo Bio Tech Ltd (511509) has a reported market cap of $501.70M (data as of 2026-07-10).
What is 511509's P/E ratio?
The price-to-earnings (P/E) ratio for Vivo Bio Tech Ltd (511509) is -26.29 (data as of 2026-07-10).
Does Vivo Bio Tech Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Vivo Bio Tech Ltd (511509). Check the MyAverix Finance app for the latest dividend data.
What sector is Vivo Bio Tech Ltd in?
Vivo Bio Tech Ltd (511509) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 511509 listed on?
511509 is listed on NS.
What is Vivo Bio Tech Ltd's net margin?
Vivo Bio Tech Ltd (511509) reports a net margin of 5.6% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.